NOVACYT SIGNS STRATEGIC ALLIANCE WITH CEPHEID FOR HPV DIAGNOSTICS IN LATIN AMERICA

strategic-alliance-agreement-with-cepheid Paris, France and Cambridge, UK – 4th October 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has entered into a strategic alliance with Cepheid Inc., a leading international molecular diagnostics company, to introduce a complete Human Papillomavirus (HPV) diagnostic system into Latin America.

Visit Page

Novacyt to collaborate to validate HPV testing with NOVAprep® technology

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has announced it will validate the NOVAprep® liquid-based cytology platform with Abbott’s RealTime High Risk HPV (Human papillomavirus) assay. Download press release

Visit Page